TITLE

New perspectives in lung cancer. 4. Haematopoietic growth factors and lung cancer treatment

AUTHOR(S)
Thatcher, N
PUB. DATE
February 1992
SOURCE
Thorax;Feb1992, Vol. 47 Issue 2, p119
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66097603

 

Related Articles

  • Health & Science.  // Time;11/7/2011, Vol. 178 Issue 18, p16 

    The article notes seven steps in lung cancer diagnosis and treatment, mutations in lung cancer that can affect epidermal-growth-factor receptors (EGFR), the use of DNA-based therapy in lung cancer treatment, and potential treatments for five cancers including breast, prostate, and melanoma.

  • Smoking, treatment for Hodgkin's Disease, and subsequent lung cancer risk. Boivin, Jean-Francois // JNCI: Journal of the National Cancer Institute;10/18/95, Vol. 87 Issue 20, p1502 

    Editorial. Studies the effect of treatment of Hodgkin's disease and of smoking on subsequent lung cancer risk. Factors that increase lung cancer risk.

  • Will Lung Cancer Targeting Hit Its Mark? Hampton, Tracy // JAMA: Journal of the American Medical Association;4/27/2005, Vol. 293 Issue 16, p1963 

    Focuses on new studies regarding lung cancer that were presented at a conference for the American Association for Cancer Research. Discussion of therapies that target the epidermal growth factor receptor (EGFR), a protein mutated in some cancer patients; Approval of the drug erlotinib for the...

  • Lung Cancer.  // New Harvard Guide to Women's Health;2004, p338 

    Presents a comprehensive women's health guide to lung cancer, the most lethal cancer that occurs in women. Key etiology of lung cancer; Types of lung cancer; Risk factors and symptoms; Treatment protocols.

  • CITATIONS AND CLINICIANS' NOTES: BIOLOGY -- DISEASE.  // Current Medical Literature: Breast Cancer;2004, Vol. 16 Issue 4, p83 

    Discusses several studies on cancer. Impact of comorbidity on the treatment and complications of breast cancer; Diagnosis of breast cancer in young women; Epidermal growth factor receptor mutations in lung cancer.

  • Epidermal growth factor receptor--targeted therapy and symptom improvement in non-small cell lung cancer. Bonomi, Philip D. // American Journal of Health-System Pharmacy;12/15/2003 Supplement 9, Vol. 60, pS16 

    Discusses the impact of targeted therapy on the treatment of patients with advanced non-small cell lung cancer. Epidermal growth factor receptor (EGFR); Therapies targeted at EGFR; Quality of life and disease-related symptoms; Measurements of the Functional Assessment of Cancer Therapy-Lung...

  • Lung cancer. Holdstock, Ruth // Practice Nurse;11/5/2010, Vol. 40 Issue 8, p17 

    The article offers information on treatment and management of lung cancer and examines how to best support patients who are undergoing treatment for this disease. Lung cancer is considered to be the second most common cancer in Great Britain. The two main types of primary lung cancer include...

  • 综述. 肺癌细胞中HGF/c-Met信号通路的异常调控及其靶向药物研究进展. 李永文; 刘红雨; 陈军 // Chinese Journal of Lung Cancer;Aug2014, Vol. 17 Issue 8, p625 

    C-MET is a coding product of proto oncogene c-MET, hepatocyte growth factor (HGF) receptor with tyrosine kinase activity. The abnormal expression of c-Met gene is correlated with the tumorigenesis and development of lung cancer. Once the tyrosine kinase is activated by the interaction between...

  • Targeted therapies: Insights from exceptional responders. Villanueva, M. Teresa // Nature Reviews Cancer;Oct2014, Vol. 14 Issue 10, p647 

    An abstract of the article on the therapeutic synergism of insulin-like growth factor 1 receptor and anaplastic lymphoma kinase in lung cancer treatment is presented.

  • Gefitinib Versus Cetuximab in Lung Cancer: Round One. Minna, John D.; Peyton, Michael J.; Gazdar, Adi F. // JNCI: Journal of the National Cancer Institute;8/17/2005, Vol. 97 Issue 16, p1168 

    Compares the effectiveness of gefitinib and cetuximab in the treatment of lung cancer. Mechanism of action gefitinib and cetuximab; Challenge of optimizing epidermal growth factor receptor-targeted therapy.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics